Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.
2.

Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.

de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O.

Nutrition. 2010 Nov-Dec;26(11-12):1130-3. doi: 10.1016/j.nut.2008.11.019. Epub 2009 Feb 10.

PMID:
19211226
3.

Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.

Haider DG, Schindler K, Mittermayer F, Müller M, Nowotny P, Rieger A, Luger A, Ludvik B, Wolzt M.

Clin Pharmacol Ther. 2007 Apr;81(4):580-5. Epub 2007 Jan 18. Erratum in: Clin Pharmacol Ther. 2007 Apr;81(4):611.

PMID:
17235334
4.

Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors.

Frati AC, Iniestra F, Ariza CR.

Diabetes Care. 1996 Feb;19(2):112-8.

PMID:
8718429
5.

Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?

Cengiz C, Ardicoglu Y, Bulut S, Boyacioglu S.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):813-9. doi: 10.1097/MEG.0b013e32833283cb.

PMID:
19820404
6.

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM.

Diabetes Obes Metab. 2007 Jan;9(1):65-9.

PMID:
17199720
7.

Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.

Gannagé-Yared MH, Azar RR, Amm-Azar M, Khalifé S, Germanos-Haddad M, Neemtallah R, Halaby G.

Metabolism. 2005 Jul;54(7):947-51.

PMID:
15988706
8.

Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.

Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, Dietz E, Norman K, Buning C, Winklhofer-Roob BM, Lochs H, Ockenga J.

Nutrition. 2009 Feb;25(2):172-81. doi: 10.1016/j.nut.2008.07.020. Epub 2008 Oct 11.

PMID:
18849144
9.

[The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman--preliminary report].

Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A.

Przegl Lek. 2007;64(2):70-3. Polish.

PMID:
17892035
10.

Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.

Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T.

Clin Sci (Lond). 2002 Aug;103(2):137-42.

PMID:
12149104
11.

Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.

Schindler K, Haider D, Wolzt M, Rieger A, Gmeinhart B, Luger A, Nowotny P, Ludvik B.

Eur J Clin Invest. 2006 Sep;36(9):640-6.

PMID:
16919047
12.

Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.

Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.

Ren Fail. 2007;29(2):147-54.

PMID:
17365928
13.

Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.

de Luis DA, Sagrado MG, Conde R, Aller R, Izaola O.

Nutrition. 2013 Nov-Dec;29(11-12):1300-3. doi: 10.1016/j.nut.2008.11.005. Epub 2009 Jan 8.

PMID:
19131213
14.

Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects.

Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al Sharafi A, Abdella N.

Ann Nutr Metab. 2008;52(4):329-34. doi: 10.1159/000151487. Epub 2008 Aug 19.

PMID:
18714151
15.

Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.

Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY.

Clin Chim Acta. 2008 Jan;387(1-2):31-5. Epub 2007 Sep 1.

PMID:
17884030
16.

Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Yamano G, Yanagawa T, Ohgushi M, Ohya M, Yoshii S, Taki Y, Seino Y.

Metabolism. 2005 Mar;54(3):376-80.

PMID:
15736116
17.

Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy.

Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A.

J Int Med Res. 2012;40(2):583-9.

PMID:
22613419
18.

Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.

Stadler M, Storka A, Theuer EA, Krebs M, Vojtassakova E, Nowotny P, Pacini G, Kästenbauer T, Luger A, Prager R, Wolzt M, Anderwald C.

Clin Endocrinol (Oxf). 2010 Jun;72(6):763-9. doi: 10.1111/j.1365-2265.2009.03709.x. Epub 2009 Sep 21.

PMID:
19769621
19.

Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.

Wang P, Bai C, Xu QY, Xu TY, Su DF, Sassard J, Miao CY.

Clin Exp Pharmacol Physiol. 2010 Sep;37(9):894-9. doi: 10.1111/j.1440-1681.2010.05402.x. Epub 2010 Apr 26.

PMID:
20456420
20.

Supplemental Content

Support Center